Journals / Archives of Clinical and Experimental Medicine / 2020 / Cilt: 5 - Sayı: 2

Efficacy of Genetic Sonogram For Predicting Aneuploidy In a High-Risk Pregnancy Population

Pages
69–74
Publication Date
2020-08-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: İn some countries, where NIPT are not thoroughly diffused,Genetic sonography is recommended for Down syndrome risk modification in high-risk pregnancies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AİM: This study evaluates the efficacy of genetic sonogram for predicting aneuploidy in high-risk pregnancies.
📊
Key Findings & Data:METHODS: This retrospective study included 1363 pregnant women who underwent a second trimester genetic sonogram due to high-risk pregnancy.
💡
Conclusion & Impact:CONCLUSION: İn some countries, where NIPT are not thoroughly diffused,Genetic sonography is recommended for Down syndrome risk modification in high-risk pregnancies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:aneuploidy · pregnancy · genetic sonogram

Abstract

AİM: This study evaluates the efficacy of genetic sonogram for predicting aneuploidy in high-risk pregnancies. METHODS: This retrospective study included 1363 pregnant women who underwent a second trimester genetic sonogram due to high-risk pregnancy. Sensitivity, specificity, odds ratio, (+) and (-) likelihood ratios were calculated for each of the ultrasonography markers. RESULTS: Among the high-risk pregnancy study population, there was no significant difference regarding advanced maternal age, presence of a relative with Down Syndrome, history of anomaly in the previous pregnancy, hyperechogenic bowels, pyelectasis, nuchal fold thickness > 5 mm, ventriculomegaly, choroid plexus cyst, single umbilical artery, or presence of right echogenic intracardiac focus between the control and aneuploidy groups (p>0.05). Tricuspid regurgitation, hypoplasia/absence of nasal bone, short femur, short humerus and left echogenic intracardiac focus were associated with increased risk of aneuploidy (p<0.05). The risk of aneuploidy was increased by 14.45 fold (95% CI 2.90-71.85) in cases with tricuspid regurgitation, 18.01 (5.46-59.32) fold by hypoplasia/absence of nasal bone, 9.74 (3.70-25.65) fold by presence of short femur, 11.42 (4.30-30.30) fold by presence of short humerus, and 4.20 (1.39-12.64) fold with the presence of left echogenic intracardiac focus. Analysis of combined markers showed that hypoplasia/absence of nasal bone + short humerus + tricuspid regurgitation resulted in the highest risk (OR = 11.20, LHR = 7.53). CONCLUSION: İn some countries, where NIPT are not thoroughly diffused,Genetic sonography is recommended for Down syndrome risk modification in high-risk pregnancies.

🔖

Cite This Article

TOKER, F., ŞIK, B. A., ABA, Y. A. (2020). Efficacy of Genetic Sonogram For Predicting Aneuploidy In a High-Risk Pregnancy Population. Archives of Clinical and Experimental Medicine, Cilt: 5 - Sayı: 2, 69–74. https://ajindex.com/articles/712830

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. ACOG Committee Opinion: Down Syndrome Screening. Publication No. 141, 1994, American College of Obstetricians and Gynecologists, Washington, DC
  2. Lynch L, Berkowitz RL: Amniocentesis, Skin Biopsy, Umblical Cord Blood Sampling in the Prenatal Diagnosis of Genetic Disorders. in Reece EA, Hobbins JC, Mahoney MJ. (eds): Medicine of the Fetus and Mother. Philadelphia. JB. Lippincott, 1992, pp 641-652 3. Scott F, Peters H, Boogert T et al. The loss rates for invasive prenatal testing in a specialised obstetric ultrasound practice. Aust N Z J Obstet Gynaecol 2002; 42: 55-8
  3. Nyberg DA, Souter VL. Sonographic markers of fetal aneuploidy. Clin Perinatol 2000; 27: 761-89
  4. Vintzileos AM, Egan JF. Adjusting the risk for trisomy 21 on the basis of second trimester ultrasonography. Am J Obstet Gynecol, 1995; 172: 837-844. 6.American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol 2007;110: 1459–67
  5. Benacerraf BR, Neuberg D, Bromley B, Frigoletto FD Jr. Sonographic scoring index for prenatal detection of chromosomal abnormalities. J Ultrasound Med 1992; 11: 449-58
  6. Odibo AO, Sehdev HM, Gerkowicz S, Stamilio DM, Macones GA. Comparison of the efficiency of second-trimester nasal bone hypoplasia and increased nuchal fold in Down syndrome screening. Am J Obstet Gynecol 2008;199:281.e1–5. 9.Vos FI, De Jong-Pleij EA, Ribbert LS, Tromp E, Bilardo CM. Three-dimensional ultrasound imaging and measurement of nasal bone length, prenasal thickness and frontomaxillary facial angle in normal second- and thirdtrimester fetuses. Ultrasound Obstet Gynecol 2012;39:636–41. 10.Fehmi Yazıcıoğlu H, Sevket O, Akın H, Aygün M, Özyurt ON, Karahasanoğlu A. Aberrant right subclavian artery in Down syndrome fetuses. Prenat Diagn 2013;33:209–13
  7. Faiola S, Tsoi E, Huggon IC, Allan LD, Nicolaides KH. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitatiom at the 11 to 13+6 week scan. Ultrasound Obstet Gynecol 2005;26:22-7 12. Vintzileos AM, Campbell WA, Rodis JF, Guzman ER, Smulian JC, Knuppel RA. The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21. Obstet Gynecol 1996; 87: 948-52. 13.Cicero S, Sonek JD, McKenna DS, Croom CS, Johnson L, Nicolaides KH. Nasal bone hypoplasia in trisomy 21 at 15-22 weeks’ gestation. Ultrasound Obstet Gynecol. 2003;21:15-18. 14.Bromley B, Lieberman E, Shipp TD, B